The Analysis of the Relationship Between A1298C and C677T Polymorphisms of the MTHFR Gene with Prostate Cancer in Eskisehir Population
- 1 October 2009
- journal article
- research article
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 13 (5) , 641-645
Abstract
Prostate cancer is the most common cause of cancer deaths in men and is a major health problem worldwide. Methylene tetrahydrofolate reductase (MTHFR) plays an important role for folate metabolism and is also an important source for DNA methylation and DNA synthesis (nucleotide synthesis). The objective of this study was to investigate the relationship between the A1298C and C677T polymorphisms of the MTHFR gene and prostate cancer in the Turkish population. In our study, 93 prostate cancer patients between the ages of 50–89 and a control group of 166 benign prostate hyperplasia patients were evaluated. C677T and A1298C polymorphism ratios were compared among these two groups, and an analysis was made to see if there is a statistically meaningful difference. In this study, it has been observed that C677T polymorphism of the MTHFR gene produces no statistically significant difference for T allele frequency and the genotype frequency in prostate cancer patients and male controls with benign prostate hyperplasia not having prostate cancer, whereas it has been observed that A1298C polymorphism produces a statistically significant difference for C allele frequency in prostate cancer patients and controls and that it also produces a statistically marginal significance for genotype frequencies.Keywords
This publication has 40 references indexed in Scilit:
- MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controlsEuropean Journal of Cancer, 2009
- Estrogen receptor activation and estrogen-regulated gene expression are unaffected by methylseleninic acid in LNCaP prostate cancer cellsThe Journal of Nutritional Biochemistry, 2007
- Mechanisms Underlying the Development of Androgen-Independent Prostate CancerClinical Cancer Research, 2006
- Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case–control studyEuropean Journal Of Cancer Prevention, 2006
- Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer TrialBJU International, 2003
- A Genomic Scan of Families with Prostate Cancer Identifies Multiple Regions of InterestThe American Journal of Human Genetics, 2000
- A Genome Screen of Multiplex Sibships with Prostate CancerThe American Journal of Human Genetics, 2000
- Evidence for a Rare Prostate Cancer–Susceptibility Locus at Chromosome 1p36The American Journal of Human Genetics, 1999
- Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study GroupJAMA, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995